Novo Nordisk exec: In the digital age, it’s not enough to have a better molecule

Much of Dr. Todd Hobbs’ life has centered around diabetes – he was diagnosed with Type I diabetes roughly 30 years ago and now he is the father of a child with diabetes. At his Kentucky-based primary care practice, he took on diabetic patients and helped manage their care.

And when he made the jump from the clinic to the pharmaceutical industry 15 years ago, he accepted a job at Novo Nordisk (NYSE:NVO). He now serves as VP & CMO of the insulin-maker’s North America unit.

Between his work as a doctor and as an executive, he has watched healthcare trends come and go. The one that he’s keeping a close eye on nowadays? Digital health.

Get the full story at our sister site, Drug Delivery Business News.

The post Novo Nordisk exec: In the digital age, it’s not enough to have a better molecule appeared first on MassDevice.

from MassDevice https://ift.tt/2uVnEUB